Does teen cannabis use raise psychosis risk?

What the new evidence shows

A very large follow-up study tracked more than 400,000 adolescents into adulthood and found a measurable link between recent cannabis use during the teen years and later diagnoses of serious mental illnesses, including psychotic and bipolar disorders. Teenagers who reported using cannabis within the past year were more likely, on average, to develop these conditions in later years than peers who did not.

What researchers and clinicians take from this - The finding strengthens concerns that cannabis use in adolescence — a period when the brain is still developing — may be associated with elevated long-term psychiatric risk. - The study establishes an association rather than definitive proof of cause. Multiple pathways could contribute, including genetic vulnerability, co-occurring substance use, social factors, or the biological effects of cannabinoids on a developing brain.

Practical implications - Prevention efforts that delay or reduce cannabis use among teens could lower the number who go on to develop severe psychiatric disorders. - Clinicians and school health services should screen for cannabis use, particularly in young people showing early mood or psychotic symptoms, and offer early intervention or referral when needed. - Policymakers and public health campaigns should emphasize age limits and education about mental health risks as jurisdictions consider changing cannabis laws.

What remains uncertain - The precise magnitude of risk for any given individual and how factors like frequency, potency, or age of first use modify that risk are still being studied. - Further research is needed to untangle causal mechanisms and to identify which adolescents are at greatest risk so interventions can be targeted effectively.